Assessment of Drug Sensitivity in Hematopoietic Stem and Progenitor Cells from Acute Myelogenous Leukemia and Myelodysplastic Syndrome Ex Vivo

Current understanding suggests that malignant stem and progenitor cells must be reduced or eliminated for prolonged remissions in myeloid neoplasms such as acute myelogenous leukemia (AML) or myelodysplastic syndrome (MDS). Multicolor flow cytometry has been widely used to distinguish stem and myelo...

Descripción completa

Detalles Bibliográficos
Autores principales: Knorr, Katherine L.B., Finn, Laura E., Smith, B. Douglas, Hess, Allan D., Foran, James M., Karp, Judith E., Kaufmann, Scott H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Translational Research Articles and Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442784/
https://www.ncbi.nlm.nih.gov/pubmed/28297583
http://dx.doi.org/10.5966/sctm.2016-0034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442784/
https://www.ncbi.nlm.nih.gov/pubmed/28297583
http://dx.doi.org/10.5966/sctm.2016-0034

Ejemplares similares